                         SEQUENCE LISTING

<110>  Albert-Ludwigs-Universitt Freiburg +
       Baker IDI Heart & Diabetes Institute Holdings Ltd.
 
<120>  Antibodies for the selective inhibition of inflammation and 
       pharmaceutical compositions containing such antibodies

<130>  PWO00288ALB

<150>  EP16175382.7
<151>  2016-06-21

<160>  17    

<170>  PatentIn version 3.5

<210>  1
<211>  107
<212>  PRT
<213>  artificial sequence

<220>
<223>  light chain

<400>  1

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Leu Gly 
1               5                   10                  15      


Glu Arg Val Ser Leu Thr Cys Arg Ala Ser Gln Glu Ile Ser Gly Tyr 
            20                  25                  30          


Leu Ser Trp His Gln Gln Lys Pro Asp Gly Thr Ile Lys Arg Leu Leu 
        35                  40                  45              


Tyr Ser Thr Ser Thr Leu Asp Ser Gly Val Pro Lys Arg Phe Ser Gly 
    50                  55                  60                  


Ser Arg Ser Gly Ser Asp Tyr Ser Leu Thr Ile Ser Ser Leu Glu Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Asp Tyr Tyr Cys Leu Gln Tyr Ala Ile Ser Pro Pro 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  2
<211>  6
<212>  PRT
<213>  artificial sequence

<220>
<223>  CDR 1

<400>  2

Gln Glu Ile Ser Gly Tyr 
1               5       


<210>  3
<211>  3
<212>  PRT
<213>  artificial sequence

<220>
<223>  CDR 2

<400>  3

Ser Thr Ser 
1           


<210>  4
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  CDR 3

<400>  4

Leu Gln Tyr Ala Ile Ser Pro Pro Thr 
1               5                   


<210>  5
<211>  121
<212>  PRT
<213>  artificial sequence

<220>
<223>  heavy chain

<400>  5

Gln Val Thr Leu Lys Glu Ser Gly Pro Gly Ile Leu Gln Thr Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ser Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Met Gly Val Ser Trp Ile Arg Gln Pro Ser Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Leu Ala His Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Ser Lys Asp Thr Ser Arg Asn Gln Val 
65                  70                  75                  80  


Phe Leu Lys Ile Thr Ser Val Asp Thr Thr Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Leu Asn Tyr Tyr Asn Ser Thr Tyr Asn Phe Asp Phe Trp Gly 
            100                 105                 110         


Gln Gly Thr Thr Leu Thr Val Ser Ser 
        115                 120     


<210>  6
<211>  10
<212>  PRT
<213>  artificial sequence

<220>
<223>  CDR1

<400>  6

Gly Phe Ser Leu Ser Thr Ser Gly Met Gly 
1               5                   10  


<210>  7
<211>  7
<212>  PRT
<213>  artificial sequence

<220>
<223>  CDR 2

<400>  7

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  8
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  CDR 3

<400>  8

Ala Leu Asn Tyr Tyr Asn Ser Thr Tyr Asn Phe Asp Phe 
1               5                   10              


<210>  9
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide

<400>  9

Glu Gln Leu Lys Lys Ser Lys Thr Leu 
1               5                   


<210>  10
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide M7

<400>  10

Glu Gln Phe Lys Lys Ser Lys Thr Leu 
1               5                   


<210>  11
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  artificial sequence

<400>  11

Val Met Glu Gln Leu Lys Lys Ala Lys Thr Leu Met Gln 
1               5                   10              


<210>  12
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide

<400>  12

Lys Leu Ser Leu Glu Lys Gln Thr Lys 
1               5                   


<210>  13
<211>  8
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide

<400>  13

Glu Glu Phe Arg Ile His Phe Thr 
1               5               


<210>  14
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide M1

<400>  14

Pro His Asp Phe Arg Arg Met Lys Glu Phe Val Ser Thr 
1               5                   10              


<210>  15
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide M1

<400>  15

Asn Ile Asp Phe Gln Lys Met Lys Glu Phe Val Ser Thr 
1               5                   10              


<210>  16
<211>  8
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide M8

<400>  16

Asp Glu Phe Arg Ile His Phe Thr 
1               5               


<210>  17
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  peptide

<400>  17

Val Met Glu Gln Leu Lys Lys Ser Lys Thr Leu Phe Ser 
1               5                   10              


